Ocular Therapeutix (OCUL) Retained Earnings: 2013-2025
Historic Retained Earnings for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to -$1.1 billion.
- Ocular Therapeutix's Retained Earnings fell 29.63% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 29.63%. This contributed to the annual value of -$891.1 million for FY2024, which is 27.74% down from last year.
- According to the latest figures from Q3 2025, Ocular Therapeutix's Retained Earnings is -$1.1 billion, which was down 6.79% from -$1.0 billion recorded in Q2 2025.
- Ocular Therapeutix's Retained Earnings' 5-year high stood at -$536.1 million during Q1 2021, with a 5-year trough of -$1.1 billion in Q3 2025.
- In the last 3 years, Ocular Therapeutix's Retained Earnings had a median value of -$806.2 million in 2024 and averaged -$823.1 million.
- Data for Ocular Therapeutix's Retained Earnings shows a maximum YoY crashed of 32.34% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Ocular Therapeutix's Retained Earnings stood at -$545.8 million in 2021, then fell by 13.02% to -$616.8 million in 2022, then dropped by 13.09% to -$697.6 million in 2023, then declined by 27.74% to -$891.1 million in 2024, then dropped by 29.63% to -$1.1 billion in 2025.
- Its last three reported values are -$1.1 billion in Q3 2025, -$1.0 billion for Q2 2025, and -$955.1 million during Q1 2025.